Today: 21 April 2026
SoFi Stock Slides Despite CEO Buy, Record Q4 and Mastercard Stablecoin Deal

SoFi Stock Slides Despite CEO Buy, Record Q4 and Mastercard Stablecoin Deal

NEW YORK, March 10, 2026, 6:18 PM EDT

SoFi Technologies dropped roughly 2.6% to $18.29 in late Tuesday trading in the U.S.

The action followed CEO Anthony Noto’s insider buy on March 2 and the March 3 Mastercard deal tied to SoFiUSD. Investors are still being asked to believe in SoFi’s growth prospects, even as they absorb the hit from last year’s stock sales—$3.3 billion brought in, according to the company.

Fintech names took hits on Tuesday, with Affirm dropping around 2.0% and PayPal off about 2.5%. SoFi, meanwhile, was trading at nearly 50 times earnings—more expensive than PayPal’s 13 but sitting below Affirm’s 78.5.

San Francisco-based SoFi isn’t shy about its numbers. In the Jan. 30 release, CEO Anthony Noto dubbed the fourth quarter “nothing short of exceptional” as the company delivered record adjusted net revenue — roughly $1.0 billion. Adjusted EBITDA landed at $318 million, with fee-based revenue showing $443 million on the books. Membership hit 13.7 million by the close of 2025, while products reached 20.2 million. Revenue from SoFi’s financial-services arm surged 78% to $456.7 million, according to Reuters. Q4 Holdings

According to a Form 4, Noto snapped up 56,000 SoFi shares on March 2, paying a weighted average of $17.8842 per share. That bump takes his direct stake to 11.68 million shares. The filing flagged a notable open-market buy from the chief executive.

SoFi is pushing to broaden its narrative past just lending. Back on March 3, the company revealed that Mastercard would start letting transactions settle in SoFiUSD, a dollar-backed stablecoin meant to maintain a constant value, right on Mastercard’s network. SoFi Bank plans to handle its own Mastercard credit and debit settlements in SoFiUSD as well. CEO Anthony Noto called SoFiUSD “at the heart of our strategy” to speed up, cut costs, and bolster safety in moving money. SoFi

SoFi’s take: yes, last year’s stock sales were dilutive, but in return, the company locked in lower-cost funding and beefed up its capital. Some proceeds went straight to paying down warehouse lines—those short-term loan funding facilities. According to its most recent earnings release, deposits carry a cost that’s 181 basis points, or 1.81 percentage points, lower than warehouse lines, which works out to roughly $679.8 million in annualized interest expense savings.

Risks are still on the table. SoFi flagged that broader SoFiUSD adoption hinges on regulatory signoff and Mastercard network requirements, and the firm’s tech-platform enabled accounts slumped 23% in Q4 after a major client exit. Should loan expansion stall or credit losses tick up, a stock priced at roughly 50 times earnings faces the risk of renewed selling.

Stock Market Today

  • Sensex surges 753 points as US-Iran peace talks boost Indian markets
    April 21, 2026, 11:33 AM EDT. The Sensex jumped 753 points to 79,273.33 and the Nifty 50 crossed 24,550 amid growing optimism over US-Iran peace talks, easing crude oil prices, and strong earnings from key sectors. The market capitalization of BSE-listed companies rose by ₹3 lakh crore in one day, reaching nearly ₹469 lakh crore. Banking and FMCG stocks led the gains, with Nestle India, Hindustan Unilever, and Trent as top gainers. Sectoral indices like Nifty Bank and FMCG surged, while Pharma and Consumer Durables slipped slightly. Analysts said easing geopolitical tensions and falling crude prices lifted risk appetite, despite mid and small-cap segments underperforming. Investors remain focused on corporate earnings and global developments.

Latest article

Eli Lilly to Buy Kelonia for Up to $7 Billion as In Vivo CAR-T Gains Ground

Eli Lilly to Buy Kelonia for Up to $7 Billion as In Vivo CAR-T Gains Ground

21 April 2026
Eli Lilly will acquire Boston-based Kelonia Therapeutics for up to $7 billion in cash, including $3.25 billion upfront, to expand into in vivo CAR-T cancer therapies. Kelonia’s KLN-1010, in Phase 1 for multiple myeloma, generates engineered T-cells inside the patient. The deal marks Lilly’s third Massachusetts biotech purchase in 2026. Kelonia had 62 employees and nearly ran out of cash before the offer.
POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

21 April 2026
POET Technologies shares surged 20% Tuesday, following an 18% gain Monday, after the company addressed U.S. shareholder tax concerns and announced plans to redomicile. Nearly 32.9 million shares traded by 10:21 a.m. ET, with the stock reaching $11.07 before settling at $10.34. Wolfpack Research disclosed a short position last week, sparking volatility. CFO Thomas Mika said POET expects not to qualify as a PFIC in 2026.
Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

21 April 2026
Rocket Lab shares rose 2% to $91.12 Tuesday after analysts raised price targets and the Pentagon detailed new space defense spending in its 2027 budget request. The company closed its $155 million Mynaric acquisition last week and reported a $190 million Pentagon launch contract in March, bringing its backlog above $2 billion. Rocket Lab now expects to launch its Neutron rocket in late 2026 after a test setback.
Nokia Oyj Executive Sells 150,000 Shares as AI Pivot Faces Fresh Test
Previous Story

Nokia Oyj Executive Sells 150,000 Shares as AI Pivot Faces Fresh Test

Plug Power Eyes 250 MW PJM Power Bid in New AI Data Center Push
Next Story

Plug Power Eyes 250 MW PJM Power Bid in New AI Data Center Push

Go toTop